NCT06073132: An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 80 planned
- Started
- 4 Apr 2024
- Primary completion
- 10 Jun 2026
- Arms
- Part A AC-203, Part B AC-203
- Results
- None posted
- 10 Oct 2023: Trial registered
- 4 Apr 2024: Trial started